Federal Trade Commission enforcement against human chorionic gonadotropin weight-loss products is the tip of the iceberg in the agency’s concerns about homeopathic product claims, questions that sometimes conflict with FDA’s oversight of the products.
FTC on Dec
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?